Summary-of-new-EU-Clinical-Trial-Regulation

The changes the regulation brings companies need to already be reviewing their current processes, systems and supporting infrastructure for clinical trial applications and operations. They need to do so in every changing regulatory environment where Clinical Trial and related data is being ever more scrutinized.

This Whitepaper provides a synopsis of the new regulation

• Insights on timing
• The advantages of preparedness.
• The impact that Brexi
• How companies can set up a successful CTR Programme